Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Retained Earnings (2016 - 2025)

Conmed's Retained Earnings history spans 16 years, with the latest figure at -$46.3 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 108.26% year-over-year to -$46.3 million; the TTM value through Dec 2025 reached -$46.3 million, down 108.26%, while the annual FY2025 figure was -$46.3 million, 108.26% down from the prior year.
  • Retained Earnings reached -$46.3 million in Q4 2025 per CNMD's latest filing, down from $572.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $575.4 million in Q2 2025 to a low of -$60.1 million in Q3 2022.
  • Average Retained Earnings over 5 years is $79.6 million, with a median of -$41.5 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: plummeted 12540.3% in 2021, then skyrocketed 2463.46% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$54.2 million in 2021, then skyrocketed by 32.46% to -$36.6 million in 2022, then plummeted by 37.05% to -$50.2 million in 2023, then surged by 1216.76% to $560.3 million in 2024, then plummeted by 108.26% to -$46.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Retained Earnings are -$46.3 million (Q4 2025), $572.0 million (Q3 2025), and $575.4 million (Q2 2025).